Ensign Group Inc (NASDAQ: ENSG) on Friday, plunged -1.62% from the previous trading day, before settling in for the closing price of $183.54. Within the past 52 weeks, ENSG’s price has moved between $118.73 and $193.99.
Annual sales at Healthcare sector company grew by 20.98% over the past five years. The company achieved an average annual earnings per share of 18.31%. With a float of $55.91 million, this company’s outstanding shares have now reached $57.90 million.
Ensign Group Inc (ENSG) Insider Updates
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Ensign Group Inc is 3.48%, while institutional ownership is 95.09%. The most recent insider transaction that took place on Jan 02 ’26, was worth 121,513. In this transaction Director of this company sold 700 shares at a rate of $173.59, taking the stock ownership to the 23,652 shares. Before that another transaction happened on Jan 02 ’26, when Company’s Director proposed sale 700 for $173.59, making the entire transaction worth $121,513.
Ensign Group Inc (ENSG) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 1.49 earnings per share (EPS) for the period topping the consensus outlook (set at 1.48) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.35% during the next five years compared to 20.98% growth over the previous five years of trading.
Ensign Group Inc (NASDAQ: ENSG) Trading Performance Indicators
Ensign Group Inc (ENSG) is currently performing well based on its current performance indicators. A quick ratio of 1.46 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.17. Likewise, its price to free cash flow for the trailing twelve months is 36.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.62, a number that is poised to hit 1.75 in the next quarter and is forecasted to reach 7.27 in one year’s time.
